Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Sell
38
BDUUY Quote, Financials, Valuation and Earnings
Last price:
$32.33
Seasonality move
:
1.16%
Day range:
$32.33 - $32.33
52-week range:
$31.21 - $32.33
Dividend yield:
2.78%
P/E ratio:
28.07x
P/S ratio:
4.20x
P/B ratio:
4.39x
Volume:
--
Avg. volume:
--
1-year change:
3.58%
Market cap:
$12.8B
Revenue:
$3.1B
EPS (TTM):
$1.15
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BDUUY
Bangkok Dusit Medical Services PCL
|
-- | -- | -- | -- | -- |
|
AMS
American Shared Hospital Services
|
$8.6M | $0.04 | 18.76% | -92.73% | $4.84 |
|
BUGDF
Bumrungrad Hospital PCL
|
-- | -- | -- | -- | -- |
|
CVM
CEL-SCI
|
-- | -- | -- | -- | $8.00 |
|
NIVF
NewGenIvf Group
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BDUUY
Bangkok Dusit Medical Services PCL
|
$32.33 | -- | $12.8B | 28.07x | $0.47 | 2.78% | 4.20x |
|
AMS
American Shared Hospital Services
|
$2.68 | $4.84 | $17.3M | 7.88x | $0.00 | 0% | 0.64x |
|
BUGDF
Bumrungrad Hospital PCL
|
$7.91 | -- | $6.3B | 31.15x | $0.09 | 1.86% | 9.41x |
|
CVM
CEL-SCI
|
$0.24 | $8.00 | $18.5M | -- | $0.00 | 0% | -- |
|
NIVF
NewGenIvf Group
|
$0.41 | -- | $696.2K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BDUUY
Bangkok Dusit Medical Services PCL
|
9.5% | 0.165 | 2.37% | 0.94x |
|
AMS
American Shared Hospital Services
|
45.9% | 0.382 | 90.05% | 1.35x |
|
BUGDF
Bumrungrad Hospital PCL
|
0.09% | -0.086 | 0.01% | 4.21x |
|
CVM
CEL-SCI
|
-- | 1.752 | -- | -- |
|
NIVF
NewGenIvf Group
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BDUUY
Bangkok Dusit Medical Services PCL
|
$304.7M | $156.2M | 14.33% | 15.75% | 19.66% | $11.1M |
|
AMS
American Shared Hospital Services
|
$1.4M | -$553K | 8.36% | 13.75% | -3.47% | -$407K |
|
BUGDF
Bumrungrad Hospital PCL
|
$94.5M | $62.3M | 29.88% | 29.91% | 33.84% | $59.5M |
|
CVM
CEL-SCI
|
-- | -$6.9M | -- | -- | -- | -$4.2M |
|
NIVF
NewGenIvf Group
|
-- | -- | -- | -- | -- | -- |
Bangkok Dusit Medical Services PCL vs. Competitors
-
Which has Higher Returns BDUUY or AMS?
American Shared Hospital Services has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of -2.96%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat American Shared Hospital Services's return on equity of 13.75%.
Company Gross Margin Earnings Per Share Invested Capital BDUUYBangkok Dusit Medical Services PCL37.83% $0.32 $3.3B AMSAmerican Shared Hospital Services19.57% -$0.03 $54.2M -
What do Analysts Say About BDUUY or AMS?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand American Shared Hospital Services has an analysts' consensus of $4.84 which suggests that it could grow by 80.6%. Given that American Shared Hospital Services has higher upside potential than Bangkok Dusit Medical Services PCL, analysts believe American Shared Hospital Services is more attractive than Bangkok Dusit Medical Services PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUYBangkok Dusit Medical Services PCL0 0 0 AMSAmerican Shared Hospital Services0 0 0 -
Is BDUUY or AMS More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.424, suggesting its less volatile than the S&P 500 by 57.593%.
-
Which is a Better Dividend Stock BDUUY or AMS?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.47 per share corresponding to a yield of 2.78%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUY or AMS?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than American Shared Hospital Services quarterly revenues of $7M. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than American Shared Hospital Services's net income of -$207K. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 28.07x while American Shared Hospital Services's PE ratio is 7.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 4.20x versus 0.64x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUYBangkok Dusit Medical Services PCL4.20x 28.07x $805.5M $127.4M AMSAmerican Shared Hospital Services0.64x 7.88x $7M -$207K
-
Which has Higher Returns BDUUY or BUGDF?
Bumrungrad Hospital PCL has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of 29.4%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat Bumrungrad Hospital PCL's return on equity of 29.91%.
Company Gross Margin Earnings Per Share Invested Capital BDUUYBangkok Dusit Medical Services PCL37.83% $0.32 $3.3B BUGDFBumrungrad Hospital PCL49.65% $0.06 $814M -
What do Analysts Say About BDUUY or BUGDF?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand Bumrungrad Hospital PCL has an analysts' consensus of -- which suggests that it could fall by --. Given that Bangkok Dusit Medical Services PCL has higher upside potential than Bumrungrad Hospital PCL, analysts believe Bangkok Dusit Medical Services PCL is more attractive than Bumrungrad Hospital PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUYBangkok Dusit Medical Services PCL0 0 0 BUGDFBumrungrad Hospital PCL0 0 0 -
Is BDUUY or BUGDF More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Bumrungrad Hospital PCL has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BDUUY or BUGDF?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.47 per share corresponding to a yield of 2.78%. Bumrungrad Hospital PCL offers a yield of 1.86% to investors and pays a quarterly dividend of $0.09 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. Bumrungrad Hospital PCL pays out 52.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUY or BUGDF?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than Bumrungrad Hospital PCL quarterly revenues of $190.3M. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than Bumrungrad Hospital PCL's net income of $55.9M. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 28.07x while Bumrungrad Hospital PCL's PE ratio is 31.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 4.20x versus 9.41x for Bumrungrad Hospital PCL. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUYBangkok Dusit Medical Services PCL4.20x 28.07x $805.5M $127.4M BUGDFBumrungrad Hospital PCL9.41x 31.15x $190.3M $55.9M
-
Which has Higher Returns BDUUY or CVM?
CEL-SCI has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of --. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat CEL-SCI's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BDUUYBangkok Dusit Medical Services PCL37.83% $0.32 $3.3B CVMCEL-SCI-- -$0.11 -- -
What do Analysts Say About BDUUY or CVM?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI has an analysts' consensus of $8.00 which suggests that it could grow by 3245.88%. Given that CEL-SCI has higher upside potential than Bangkok Dusit Medical Services PCL, analysts believe CEL-SCI is more attractive than Bangkok Dusit Medical Services PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUYBangkok Dusit Medical Services PCL0 0 0 CVMCEL-SCI1 0 0 -
Is BDUUY or CVM More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CEL-SCI has a beta of 0.951, suggesting its less volatile than the S&P 500 by 4.939%.
-
Which is a Better Dividend Stock BDUUY or CVM?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.47 per share corresponding to a yield of 2.78%. CEL-SCI offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. CEL-SCI pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUY or CVM?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than CEL-SCI quarterly revenues of --. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than CEL-SCI's net income of -$7.1M. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 28.07x while CEL-SCI's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 4.20x versus -- for CEL-SCI. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUYBangkok Dusit Medical Services PCL4.20x 28.07x $805.5M $127.4M CVMCEL-SCI-- -- -- -$7.1M
-
Which has Higher Returns BDUUY or NIVF?
NewGenIvf Group has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of --. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat NewGenIvf Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BDUUYBangkok Dusit Medical Services PCL37.83% $0.32 $3.3B NIVFNewGenIvf Group-- -- -- -
What do Analysts Say About BDUUY or NIVF?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand NewGenIvf Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Bangkok Dusit Medical Services PCL has higher upside potential than NewGenIvf Group, analysts believe Bangkok Dusit Medical Services PCL is more attractive than NewGenIvf Group.
Company Buy Ratings Hold Ratings Sell Ratings BDUUYBangkok Dusit Medical Services PCL0 0 0 NIVFNewGenIvf Group0 0 0 -
Is BDUUY or NIVF More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NewGenIvf Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BDUUY or NIVF?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.47 per share corresponding to a yield of 2.78%. NewGenIvf Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. NewGenIvf Group pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUY or NIVF?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than NewGenIvf Group quarterly revenues of --. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than NewGenIvf Group's net income of --. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 28.07x while NewGenIvf Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 4.20x versus -- for NewGenIvf Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUYBangkok Dusit Medical Services PCL4.20x 28.07x $805.5M $127.4M NIVFNewGenIvf Group-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
47
RGC alert for Apr 15
Regencell Bioscience Holdings [RGC] is up 4.96% over the past day.
Sell
50
SLP alert for Apr 15
Simulations Plus [SLP] is down 1.02% over the past day.
Sell
46
ZLAB alert for Apr 15
Zai Lab [ZLAB] is down 1.21% over the past day.
